On August 22, 2026, Starry Sea Acquisition Corp (SSEA) entered into an Agreement and Plan of Merger with SuperiorMed Holdings Limited to effect a business combination valued at $200 million. Under the transaction, SSEA will merge with its subsidiary Purchaser, which in turn merges with SuperiorMed, resulting in SuperiorMed becoming a wholly-owned subsidiary of the surviving entity. SuperiorMed shareholders will receive newly issued Purchaser Ordinary Shares calculated by dividing the $200 million net value by $10.00 per share. The post-merger board will consist of five directors, including one designated by SSEA and four by SuperiorMed, led by Dale Li. The transaction is subject to customary closing conditions, including shareholder approvals and SEC effectiveness of a registration statement. Starry Sea Acquisition Corp operates as a special purpose acquisition company (SPAC) formed to effect a merger or business combination with one or more businesses.